Skip to main content

Search

17 result(s) for 'author#Johanna M. W. Hazes' within BMC

Page 1 of 1

Sort by: Relevance | Date

  1. In many patients with rheumatoid arthritis (RA) subclinical disease activity can be detected with ultrasound (US), especially using power Doppler US (PDUS). However, PDUS may be highly dependent on the type of...

    Authors: David F Ten Cate, Jolanda J Luime, Myrthe van der Ven, Johanna MW Hazes, Klazina Kooiman, Nico de Jong and Johannes G Bosch
    Citation: Arthritis Research & Therapy 2013 15:R162
  2. Ultrasonography (US) might have an added value to clinical examination in diagnosing early rheumatoid arthritis (RA) and assessing remission of RA. We aimed to clarify the added value of US in RA in these situ...

    Authors: David F Ten Cate, Jolanda J Luime, Nanno Swen, Andreas H Gerards, Mike H De Jager, Natalja M Basoski, Johanna MW Hazes, Cees J Haagsma and Johannes WG Jacobs
    Citation: Arthritis Research & Therapy 2013 15:R4
  3. Changes in immunoglobulin G (IgG) constant domain (Fc) glycosylation are associated with changes in rheumatoid arthritis (RA) disease activity in response to pregnancy. Here, we sought to determine whether the...

    Authors: Albert Bondt, Manfred Wuhrer, T. Martijn Kuijper, Johanna M. W. Hazes and Radboud J. E. M. Dolhain
    Citation: Arthritis Research & Therapy 2016 18:274
  4. In a cohort of patients with newly diagnosed psoriatic arthritis (PsA) who received usual care, we investigated the impact of time elapsed to minimal disease activity (MDA) on health-related quality of life (H...

    Authors: Kim Wervers, Jolanda J. Luime, Ilja Tchetverikov, Andreas H. Gerards, Marc R. Kok, Cathelijne W. Y. Appels, Wiebo L. van der Graaff, Johannes H. L. M. van Groenendael, Lindy-Anne Korswagen, Josien J. Veris-van Dieren, Johanna M. W. Hazes and Marijn Vis
    Citation: Arthritis Research & Therapy 2019 21:25
  5. In 2008 a clinical transition pathway for young people with juvenile-onset rheumatic and musculoskeletal diseases (jRMD) aiming at improving transitional care was instituted. Historical data on drop-out rate i...

    Authors: Margot Walter, Sylvia Kamphuis, Philomine van Pelt, Annemarie de Vroed and Johanna M. W. Hazes
    Citation: Pediatric Rheumatology 2018 16:50
  6. Axial spondyloarthritis (axSpA) is a disabling inflammatory joint disease with chronic low back pain (CLBP) as leading symptom. Recognizing axSpA in the large amount of CLBP patients is difficult for general p...

    Authors: Lonneke van Hoeven, Yvonne Vergouwe, Bart W. Koes, Johanna M. W. Hazes and Angelique E. A. M. Weel
    Citation: BMC Musculoskeletal Disorders 2016 17:278
  7. Genetic and disease-related factors give rise to a wide spectrum of glucocorticoid (GC) sensitivity in rheumatoid arthritis (RA). In clinical practice, GC treatment is not adapted to these differences in GC se...

    Authors: Rogier AM Quax, Jan W Koper, Pascal HP de Jong, Ramona van Heerebeek, Angelique E Weel, Anne M Huisman, Derkjen van Zeben, Frank H de Jong, Steven WJ Lamberts, Johanna MW Hazes and Richard A Feelders
    Citation: Arthritis Research & Therapy 2012 14:R195
  8. Patients with rheumatoid arthritis (RA) can be separated into two major subpopulations based on the absence or presence of serum anti-citrullinated protein antibodies (ACPAs). The more severe disease course in...

    Authors: Sandra M. J. Paulissen, Jan Piet van Hamburg, Nadine Davelaar, Heleen Vroman, Johanna M. W. Hazes, Pascal H. P. de Jong and Erik Lubberts
    Citation: Arthritis Research & Therapy 2015 17:344
  9. Today, patients are expected to take an active role in the form of self-management. Given the burden of a rheumatic disorder, the patients cannot be expected to self-manage on their own. In order to develop se...

    Authors: Janet M.J. Been-Dahmen, Margot J. Walter, Jolanda Dwarswaard, Johanna M.W. Hazes, AnneLoes van Staa and Erwin Ista
    Citation: BMC Musculoskeletal Disorders 2017 18:84
  10. Low-dose methotrexate (MTX) is the first-line therapy in early rheumatoid arthritis (eRA). Up to 40% of eRA patients do not benefit from MTX therapy. MTX has been shown to inhibit one-carbon metabolism, which ...

    Authors: Helen R. Gosselt, Bertrand D. van Zelst, Maurits C. F. J. de Rotte, Johanna M. W. Hazes, Robert de Jonge and Sandra G. Heil
    Citation: Arthritis Research & Therapy 2019 21:157
  11. The Fc glycosylation of immunoglobulin G (IgG) is well known to associate with rheumatoid arthritis (RA) disease activity. The same may be true for other classes of Igs. In the present study, we sought to dete...

    Authors: Albert Bondt, Simone Nicolardi, Bas C. Jansen, T. Martijn Kuijper, Johanna M. W. Hazes, Yuri E. M. van der Burgt, Manfred Wuhrer and Radboud J. E. M. Dolhain
    Citation: Arthritis Research & Therapy 2017 19:160
  12. Despite recent improvements in the treatment of rheumatoid arthritis (RA), an insufficient treatment response and the development of treatment resistance in many patients illustrates the need for new therapeut...

    Authors: Wendy Dankers, Claudia González-Leal, Nadine Davelaar, Patrick S. Asmawidjaja, Adriana M. C. Mus, Johanna M. W. Hazes, Edgar M. Colin and Erik Lubberts
    Citation: Arthritis Research & Therapy 2018 20:212
  13. To understand the impact of yet undiagnosed non-radiographic axial spondyloarthritis (nr-axSpA) and ankylosing spondylitis (AS) on work outcomes in a cohort of patients with long-lasting chronic low back pain ...

    Authors: Lonneke van Hoeven, Annelies E. R. C. H. Boonen, Johanna M. W. Hazes and Angelique E. A. M. Weel
    Citation: Arthritis Research & Therapy 2017 19:143
  14. Current guidelines suggest reduction of DMARDs can be considered in RA patients in remission. Objectives were (1) to estimate the relative importance of patient characteristics rheumatologists consider in thei...

    Authors: T. Martijn Kuijper, Riëtte Folmer, Elly A. Stolk, Johanna M. W. Hazes and Jolanda J. Luime
    Citation: Arthritis Research & Therapy 2017 19:78
  15. Non-adherence to disease-modifying antirheumatic drugs (DMARDs) hampers the targets of rheumatoid arthritis (RA) treatment, obtaining low disease activity and decreasing radiological progression. This study in...

    Authors: Annelieke Pasma, Charlotte V. Schenk, Reinier Timman, Jan J. V. Busschbach, Bart J.F. van den Bemt, Esmeralda Molenaar, Willemijn H. van der Laan, Saskia Schrauwen, Adriaan van’t Spijker and Johanna M. W. Hazes
    Citation: Arthritis Research & Therapy 2015 17:281
  16. Morning stiffness is assessed daily in the diagnostic process of arthralgia and arthritis, but large-scale studies on the discriminative ability are absent. This study explored the diagnostic value of morning ...

    Authors: Jessica AB van Nies, Celina Alves, Audrey LS Radix-Bloemen, Cécile Gaujoux-Viala, Tom WJ Huizinga, Johanna MW Hazes, Elisabeth Brouwer, Bruno Fautrel and Annette HM van der Helm-van Mil
    Citation: Arthritis Research & Therapy 2015 17:108
  17. There is a lack of information about the sensitivity, specificity and costs new diagnostic tests should have to improve early diagnosis of rheumatoid arthritis (RA). Our objective was to explore the early cost...

    Authors: Leander R. Buisman, Jolanda J. Luime, Mark Oppe, Johanna M. W. Hazes and Maureen P. M. H. Rutten-van Mölken
    Citation: Arthritis Research & Therapy 2016 18:135